TMO vs LECO vs DHR Stock Comparison

Thermo Fisher Scientific, Lincoln Electric Holdings and Danaher Prices as of Nov 3, 2026 Peers: Industry group
1 more company in this comparison (RGEN) Create a free account to keep reading and compare up to 10 companies.
DHR Danaher Corp /De/
$230.08 +7.5% 1M +7.5% 1Y
Market cap
$165.27B
P/E
38.2x
Revenue (TTM)
$25.61B
Div. yield
–
Life Sciences Tools Healthcare
2 wins

Head to Head

12 decided of 12

Lincoln Electric Holdings leads on 7 of the 12 questions below (Lincoln Electric Holdings 7, Thermo Fisher Scientific 3, Danaher 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionTMOLECODHRLeader
Larger companyMarket capitalisation $260.72B $15.20B $165.27B TMO
Cheaper on earningsLower P/E, profitable companies only 36.9x 26.4x 38.2x LECO
Cheaper on forward earningsLower price / next fiscal year consensus EPS 27.0x 24.5x 25.3x LECO
Faster revenue growthRevenue growth, trailing twelve months +8.3% +11.1% +5.5% LECO
More profitableNet margin, trailing twelve months 14.9% 12.4% 16.9% DHR
Better return on capitalReturn on invested capital 8.0% 22.6% 5.8% LECO
Less leveragedLower net debt / EBITDA 3.1x 1.0x 2.6x LECO
Higher dividend yieldTrailing dividend yield 0.00% 0.01% 0.00% LECO
Better 1-year returnPrice return, last 12 months +23.6% +22.7% +7.5% TMO
Better 5-year returnAnnualised price return, 5 years +1.8%/yr +14.9%/yr -5.5%/yr LECO
Less volatileAnnualised volatility, 1 year 30.0% 31.0% 30.7% TMO
Higher overall scoreMean of the five percentile scores vs peers 59/100 56/100 60/100 DHR

Percentile Scorecard

TMOLECODHR

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisTMOLECODHR
Valuation 60 #92 of 229 36 #131 of 204 71 #67 of 229
Growth 39 #135 of 221 47 #101 of 191 26 #163 of 221
Profitability 82 #39 of 209 94 #13 of 189 86 #30 of 209
Financial Health 31 #166 of 240 46 #119 of 221 47 #127 of 240
Shareholder Returns 82 #28 of 147 55 #71 of 158 71 #43 of 147
Overall 59 56 60
  • TMO ranked among 248 companies in Medical Devices and Diagnostics
  • LECO ranked among 223 companies in Machinery
  • DHR ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodTMOLECODHRSPY
1 month +6.6%+3.7%+7.5% -2.0%
3 months +23.8%+2.5%+18.1% -2.2%
6 months +49.6%+6.7%+31.8% +4.2%
Year to date +20.5%+18.7%+0.5% +10.6%
1 year +23.6%+22.7%+7.5% +10.4%
3 years +53.6%+54.7%+16.3% +73.6%
3 years, per year +15.4%+15.7%+5.2% +20.2%
5 years +9.2%+100.0%-24.8% +61.6%
5 years, per year +1.8%+14.9%-5.5% +10.1%
10 years +378.1%+344.6%+200.6% +261.3%
10 years, per year +16.9%+16.1%+11.6% +13.7%

Risk

MeasureTMOLECODHRSPY
Volatility, 1Y 30.0%31.0%30.7% 12.8%
Downside volatility, 1Y 28.6%31.3%31.8% 12.8%
Beta vs S&P 500, 1Y 0.641.190.48 1.00
Return / volatility, 1Y 0.790.730.24 0.81
Max drawdown, 5Y -41.5%-35.3%-50.8% -25.4%
From 52-week high -1.5%-4.8%-4.9% -3.2%
52-week high $709.29$298.88$242.05 $779.14
52-week low $438.34$220.64$161.91 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleTMOLECODHR
P/E now vs peer median 36.6xmedian 28.1x 26.9xmedian 25.4x 37.4xmedian 28.1x
P/S now vs peer median 5.5xmedian 2.9x 3.3xmedian 1.9x 6.3xmedian 2.9x
EV/EBITDA now vs peer median 25.4xmedian 18.0x 18.0xmedian 14.5x 23.3xmedian 18.0x
P/FCF now vs peer median 34.1xmedian 24.8x 30.1xmedian 23.6x 28.3xmedian 24.8x
P/B now vs peer median 4.7xmedian 2.3x 9.9xmedian 2.2x 3.0xmedian 2.3x
PEG now vs peer median 4.84median 0.95 3.85median 1.21 -4.66median 0.95

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsTMOLECODHR
Revenue $47.35B $4.64B $25.61B
Gross profit $19.45B $1.65B $15.01B
Operating income $8.47B $802.52M $5.22B
Net income $7.09B $575.27M $4.33B
Free cash flow $7.60B $511.89M $5.73B
R&D $1.40B – $1.67B
EPS (diluted) $19.06 $10.48 $6.13
Cash & equivalents $5.46B $283.24M $5.68B
Total debt $41.37B $1.15B $26.48B
Shares (diluted) 371.00M 54.87M 706.80M
Enterprise value $237.23B $14.07B $144.92B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricTMOLECODHR
P/E 36.6x 26.9x 37.4x
P/FCF 34.1x 30.1x 28.3x
P/Operating cash flow 27.8x 23.1x 23.6x
P/S 5.5x 3.3x 6.3x
P/B 4.7x 9.9x 3.0x
P/Tangible book 7.1x 9.9x 5.0x
EV/EBITDA 25.4x 18.0x 23.3x
EV/EBIT 34.7x 20.3x 35.0x
EV/Revenue 6.2x 3.5x 7.1x
EV/FCF 38.7x 31.8x 31.9x
EV/Operating cash flow 31.5x 24.4x 26.6x
PEG (3Y EPS CAGR) 4.84 3.85 -4.66

Growth

14 metrics
MetricTMOLECODHR
Revenue growth (1Y) 8.3% 11.1% 5.5%
Revenue CAGR (3Y) 2.9% 4.5% 1.3%
Gross profit growth (1Y) 7.8% 7.7% 3.9%
Gross profit CAGR (3Y) 4.0% 5.5% 1.2%
Operating income growth (1Y) 12.8% 12.9% 13.1%
Operating income CAGR (3Y) 7.2% 7.0% -3.8%
Net income growth (1Y) 7.9% 9.6% 23.6%
Net income CAGR (3Y) 6.2% 4.9% -9.9%
EPS growth (1Y) 9.7% 11.0% 24.8%
EPS CAGR (3Y) 7.6% 7.0% -8.0%
Operating cash flow growth (1Y) 21.9% 0.7% 8.6%
Operating cash flow CAGR (3Y) 4.5% 0.5% -5.3%
Free cash flow growth (1Y) 24.3% -6.3% 14.2%
Free cash flow CAGR (3Y) 5.1% -3.6% -5.8%

Profitability

14 metrics
MetricTMOLECODHR
Gross margin 41.1% 35.5% 58.6%
EBITDA margin 24.4% 19.5% 30.7%
Operating margin 17.9% 17.3% 20.4%
Pretax margin 16.7% 16.2% 18.8%
Net margin 14.9% 12.4% 16.9%
FCF margin 16.0% 11.0% 22.4%
Operating cash flow margin 19.7% 14.4% 26.8%
Return on equity 13.2% 37.0% 8.2%
Return on assets 6.2% 14.9% 4.7%
Return on invested capital 8.0% 22.6% 5.8%
Return on capital employed 8.5% 27.7% 6.2%
Asset turnover 0.4x 1.2x 0.3x
Cash conversion (OCF / net income) 1.3x 1.2x 1.6x
Stock comp / revenue 0.7% 0.5% 1.3%

Financial Health

11 metrics
MetricTMOLECODHR
Debt / assets 36.2% 29.5% 28.4%
Debt / equity 0.8x 0.7x 0.5x
Net debt / EBITDA 3.1x 1.0x 2.6x
Debt / FCF 5.4x 2.2x 4.6x
Liabilities / assets 52.1% 60.1% 42.5%
Equity / assets 47.9% 39.9% 57.5%
Interest coverage 5.5x – 14.5x
Current ratio 1.8x 1.9x 1.6x
Quick ratio 1.2x 1.0x 1.1x
Cash ratio 0.4x 0.3x 0.6x
Altman Z-score 4.17 7.77 3.72

Shareholder Returns

7 metrics
MetricTMOLECODHR
Dividend yield 0.3% 1.1% 0.7%
Net buyback yield 1.6% 1.8% 0.6%
Shareholder yield 1.8% 2.9% 1.2%
Payout ratio (earnings) 9.5% 30.0% –
Payout ratio (FCF) 8.9% 33.7% –
Dividend growth (1Y) 8.0% 3.5% –
Dividend CAGR (3Y) 10.1% 6.3% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusTMOLECODHR
Forward P/E 27.0xFY2026 24.5xFY2026 25.3xFY2026
EPS, next fiscal year $25.91FY2026 $11.62FY2026 $9.11FY2026
EPS growth, next FY +13.3%FY2026 +17.7%FY2026 +16.8%FY2026
EPS growth, the year after +2.0% +0.4% +8.0%
Revenue, next fiscal year $50.12BFY2026 $4.84BFY2026 $27.01BFY2026
Revenue growth, next FY +12.5%FY2026 +14.5%FY2026 +9.9%FY2026
Revenue growth, the year after -2.8% +5.5% -1.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersTMOLECODHR
Held by institutions 90.2% 81.3% 81.9%
Institutions holding 2,627 705 2,120
Change in shares held, QoQ +0.8% +5.5% +1.1%
Institutions buying 1,145 299 842
Institutions selling 1,145 266 1,015
Buyers to sellers 1.00 1.12 0.83

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

TMOLECODHR
TMO 1.00 0.20 0.72
LECO 0.20 1.00 0.22
DHR 0.72 0.22 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, TMO, LECO and DHR?

Thermo Fisher Scientific (TMO) is the largest by market capitalisation: Thermo Fisher Scientific (TMO) $260.72B, Lincoln Electric Holdings (LECO) $15.20B, Danaher (DHR) $165.27B.

Which stock is cheaper, TMO, LECO and DHR?

Lincoln Electric Holdings (LECO) trades on the lowest price-to-earnings ratio (Thermo Fisher Scientific (TMO) 36.9x, Lincoln Electric Holdings (LECO) 26.4x, Danaher (DHR) 38.2x). On next year's consensus earnings, Lincoln Electric Holdings (LECO) is cheapest (Thermo Fisher Scientific (TMO) 27.0x, Lincoln Electric Holdings (LECO) 24.5x, Danaher (DHR) 25.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Lincoln Electric Holdings (LECO) grew revenue fastest over the trailing twelve months: Thermo Fisher Scientific (TMO) +8.3%, Lincoln Electric Holdings (LECO) +11.1%, Danaher (DHR) +5.5%.

Which company is more profitable?

Danaher (DHR) has the highest net margin (Thermo Fisher Scientific (TMO) 14.9%, Lincoln Electric Holdings (LECO) 12.4%, Danaher (DHR) 16.9%). On return on invested capital, Lincoln Electric Holdings (LECO) leads (Thermo Fisher Scientific (TMO) 8.0%, Lincoln Electric Holdings (LECO) 22.6%, Danaher (DHR) 5.8%).

Which stock has performed better?

Over the past year Thermo Fisher Scientific (TMO) returned the most: Thermo Fisher Scientific (TMO) +23.6%, Lincoln Electric Holdings (LECO) +22.7%, Danaher (DHR) +7.5%. Over five years, Lincoln Electric Holdings (LECO) compounded fastest (Thermo Fisher Scientific (TMO) +1.8%/yr, Lincoln Electric Holdings (LECO) +14.9%/yr, Danaher (DHR) -5.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Lincoln Electric Holdings (LECO) has the highest dividend yield: Thermo Fisher Scientific (TMO) 0.00%, Lincoln Electric Holdings (LECO) 0.01%, Danaher (DHR) 0.00%. Danaher (DHR) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Thermo Fisher Scientific (TMO) has been the steadiest (Thermo Fisher Scientific (TMO) 30.0%, Lincoln Electric Holdings (LECO) 31.0%, Danaher (DHR) 30.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, TMO, LECO and DHR?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Lincoln Electric Holdings (LECO) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.